AMED Amedisys Inc

Price (delayed)

$108

Market cap

$3.52B

P/E Ratio

18.43

Dividend/share

N/A

EPS

$5.86

Enterprise value

$3.99B

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients, ...

Highlights
The P/E is 54% below the 5-year quarterly average of 40.5 and 31% below the last 4 quarters average of 27.3
The quick ratio has increased by 23% YoY and by 12% QoQ
The company's debt has surged by 62% YoY
AMED's EPS is down by 9% from the previous quarter and by 5% YoY

Key stats

What are the main financial stats of AMED
Market
Shares outstanding
32.57M
Market cap
$3.52B
Enterprise value
$3.99B
Valuations
Price to earnings (P/E)
18.43
Price to book (P/B)
3.63
Price to sales (P/S)
1.58
EV/EBIT
15.02
EV/EBITDA
11.82
EV/Sales
1.8
Earnings
Revenue
$2.22B
EBIT
$265.67M
EBITDA
$337.63M
Free cash flow
$178.07M
Per share
EPS
$5.86
Free cash flow per share
$5.47
Book value per share
$29.72
Revenue per share
$68.26
TBVPS
$18.34
Balance sheet
Total assets
$1.91B
Total liabilities
$887.74M
Debt
$543.96M
Equity
$966.76M
Working capital
$12.33M
Liquidity
Debt to equity
0.56
Current ratio
1.03
Quick ratio
0.96
Net debt/EBITDA
1.4
Margins
EBITDA margin
15.2%
Gross margin
44.2%
Net margin
8.6%
Operating margin
10.4%
Efficiency
Return on assets
10.5%
Return on equity
20.8%
Return on invested capital
46.2%
Return on capital employed
17.4%
Return on sales
12%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMED stock price

How has the Amedisys stock price performed over time
Intraday
-1.56%
1 week
-0.49%
1 month
-8.11%
1 year
-56.3%
YTD
-33.28%
QTD
-37.31%

Financial performance

How have Amedisys's revenue and profit performed over time
Revenue
$2.22B
Gross profit
$981.25M
Operating income
$231.03M
Net income
$190.87M
Gross margin
44.2%
Net margin
8.6%
The company's operating margin fell by 10% YoY and by 9% QoQ
The net income has decreased by 9% QoQ and by 5% YoY
The company's net margin fell by 9% YoY and by 9% QoQ
AMED's operating income is down by 8% since the previous quarter and by 5% year-on-year

Growth

What is Amedisys's growth rate over time

Valuation

What is Amedisys stock price valuation
P/E
18.43
P/B
3.63
P/S
1.58
EV/EBIT
15.02
EV/EBITDA
11.82
EV/Sales
1.8
The P/E is 54% below the 5-year quarterly average of 40.5 and 31% below the last 4 quarters average of 27.3
AMED's EPS is down by 9% from the previous quarter and by 5% YoY
The P/B is 49% less than the 5-year quarterly average of 7.3 and 43% less than the last 4 quarters average of 6.5
AMED's equity is up by 23% year-on-year and by 3.8% since the previous quarter
The P/S is 40% less than the last 4 quarters average of 2.7 and 36% less than the 5-year quarterly average of 2.5
Amedisys's revenue has increased by 5% YoY

Efficiency

How efficient is Amedisys business performance
The ROIC has contracted by 23% YoY and by 21% from the previous quarter
The ROE has contracted by 21% YoY and by 13% from the previous quarter
The ROA has declined by 17% year-on-year and by 13% since the previous quarter
AMED's ROS is down by 8% from the previous quarter but it is up by 3.4% YoY

Dividends

What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMED.

Financial health

How did Amedisys financials performed over time
AMED's total assets is 115% higher than its total liabilities
The current ratio has increased by 24% YoY and by 8% QoQ
The quick ratio has increased by 23% YoY and by 12% QoQ
The company's debt is 44% lower than its equity
The company's debt has surged by 62% YoY
The debt to equity has grown by 30% YoY but it has contracted by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.